ReviewOncoTargets and therapy2021

Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data.

Chung-Shien Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.